此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Model of Vaginal Laxity (MVL)

2026年11月8日 更新者:Sun Xiuli、Peking University People's Hospital

Construction of Diagnostic Model for Vaginal Laxity

This study is a multicenter, prospective cohort study. The main purpose of the study is to construct diagnostic model for vaginal laxity.

研究概览

详细说明

The main purpose of the study is to construct diagnostic model for vaginal laxity based on multimodal clinical data. Besides, for the enrolled patients, we conducted follow-up for those whose vaginas could accommodate more than two fingers. According to the treatment methods they received, they were divided into three groups: Patients in Group 1 underwent pelvic floor muscle exercises, those in Group 2 received physical therapy, and those in Group 3 underwent surgical treatment. This grouping is based on clinical routine diagnosis and treatment opinions. It only observes the improvement effect of vaginal relaxation in patients of different groups and does not conduct any additional interventions on the patients. Therefore, this study is an observational study.

研究类型

观察性的

注册 (估计的)

500

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

女性

取样方法

非概率样本

研究人群

Female patients who visited the gynecology outpatient department of the participating project hospital from September 2026 to September 2027.

描述

Inclusion Criteria:

  1. Women over the age of 18 who have sex
  2. Understand and voluntarily sign the written informed consent form.

Exclusion Criteria:

  1. Gynecological examination confirmed the presence of stage III or above pelvic organ prolapse
  2. There is cognitive impairment, unable to understand the content of the questionnaire or cooperate to complete the transvaginal ultrasound examination

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

队列和干预

团体/队列
干预/治疗
Group 1: Pelvic floor muscle training

For patients whose vaginas can accommodate more than two fingers, if they undergo pelvic floor muscle exercises, they will be assigned to Group 1.

pelvic floor muscle training

Group 2: physical therapy

For patients whose vaginas can accommodate more than two fingers, if they receive physical therapy, including laser, radiofrequency, and biofeedback, they will be classified into Group 2.

laser treatment

Group 3: Surgery

For patients whose vaginas can accommodate more than two fingers, if they receive surgeries, they will be classified into Group 3.

surgery

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Construction of diagnostic model for vaginal laxity
大体时间:From enrollment to the end of treatment at 12 months

Integrating multi-model indicators to construct gold standard diagnostic model for vaginal laxity, including age (year), weight (kg), height (m), gravidity, parity, vaginal tactile imaging, pelvic floor ultrasound, POP-Q points, modified oxford muscle strength, female sex function index (FSFI), International Consultation on Incontinence Questionnaire (ICIQ), Pelvic Floor Distress Inventory-20(PFDI-20) and Overactive bladder symptom score (OABSS)

From enrollment to the end of treatment at 12 months

次要结果测量

结果测量
措施说明
大体时间
Severity of overactive bladder
大体时间:From enrollment to the end of treatment at 12 months

Overactive bladder symptom score (OABSS) questionnaire will be used to assess the severity of overactive bladder

From enrollment to the end of treatment at 12 months
Sex function
大体时间:From enrollment to the end of treatment at 12 months

Female sex function index (FSFI) questionnaire will be used to assess sex function

From enrollment to the end of treatment at 12 months
Severity of pelvic floor dysfunction
大体时间:From enrollment to the end of treatment at 12 months

Pelvic Floor Distress Inventory-20 (PFDI-20) questionnaire will be used to assess severity of pelvic floor dysfunction

From enrollment to the end of treatment at 12 months
Severity of lower urinary tract symptom
大体时间:From enrollment to the end of treatment at 12 months

International Consultation on Incontinence Questionnaire (ICIQ) will be used to assess severity of lower urinary tract symptom

From enrollment to the end of treatment at 12 months
Subjective degree of vaginal laxity
大体时间:From enrollment to the end of treatment at 12 months

The vaginal laxity questionnaire (VLQ) will be used to assess subjective degree of vaginal laxity

From enrollment to the end of treatment at 12 months
Sexual satisfaction
大体时间:From enrollment to the end of treatment at 12 months

The sexual satisfaction questionnaire (SSQ) will be used to assess sexual satisfaction

From enrollment to the end of treatment at 12 months
Patients' satisfaction for the treatment
大体时间:From enrollment to the end of treatment at 12 months

Patient Global Impression of Improvement (PGI-I) will be used to assess patients' satisfaction for the treatment.

From enrollment to the end of treatment at 12 months
Severity of pain
大体时间:From enrollment to the end of treatment at 12 months

Visual Analogue Scale (VAS) will be used to assess the severity of pain

From enrollment to the end of treatment at 12 months
Urodynamic test
大体时间:From enrollment to the end of treatment at 12 months

Urodynamic tests were performed for free uroflowmetry, post-void residual urine volume, and cystometry in the sitting position. In free uroflowmetry, the maximum flow rate (Qmax), average flow rate (Qave), and flow time were recorded, while bladder volumes were measured during the filling cystometry test at the patient's first sense, first desire, and strong desire for urination. Besides, we paid attention to whether detrusor overactivity (DO) was noted during filling cystometry. The detrusor pressure at maximum flow (PdetQmax) and the maximum urethral closure pressure (MUCP) were also measured

From enrollment to the end of treatment at 12 months
Pelvic floor ultrasound
大体时间:From enrollment to the end of treatment at 12 months

Bladder neck position, uterine descent, bladder neck descent, cervical position, retrovesical angle, rectal ampulla descent, bladder neck opening, urethral rotation angle, levator hiatus area, anorectal angle (ARA), puborectalis muscle integrity, perineal body thickness, perineal body length will be recorded.

From enrollment to the end of treatment at 12 months
Vaginal tactile imaging
大体时间:From enrollment to the end of treatment at 12 months

The images from the vaginal tactile imaging will be collected.

From enrollment to the end of treatment at 12 months
Maximum vaginal capacity index
大体时间:From enrollment to the end of treatment at 12 months
From enrollment to the end of treatment at 12 months
Modified oxford muscle strength
大体时间:From enrollment to the end of treatment at 12 months
From enrollment to the end of treatment at 12 months
Pelvic organ prolapse quantification (POP-Q)
大体时间:From enrollment to the end of treatment at 12 months
From enrollment to the end of treatment at 12 months

其他结果措施

结果测量
措施说明
大体时间
Safety of surgery
大体时间:From enrollment to the end of treatment at 12 months

The following relevant data will be collected: the duration of the surgery, the amount of bleeding, the changes in hemoglobin levels before and after the surgery, the length of hospital stay, whether there was any intraoperative organ damage, and postoperative urinary retention.

From enrollment to the end of treatment at 12 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年11月15日

初级完成 (估计的)

2028年9月30日

研究完成 (估计的)

2028年12月31日

研究注册日期

首次提交

2026年8月17日

首先提交符合 QC 标准的

2026年11月8日

首次发布 (实际的)

2026年11月12日

研究记录更新

最后更新发布 (实际的)

2026年11月12日

上次提交的符合 QC 标准的更新

2026年11月8日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • PKUPH-VL

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅